Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
RD Bruce, FL Altice, DE Moody, S Lin, WB Fang, JP Sabo, JM Wruck, C Conner, P Piliero, L Andrews, GH FriedlandVolume:
11
Language:
english
Pages:
1
DOI:
10.1186/1758-2652-11-s1-p240
Date:
November, 2008
File:
PDF, 65 KB
english, 2008